Vital KSK Holdings, Inc.

Equities

3151

JP3778280002

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-06-14 am EDT 5-day change 1st Jan Change
1,329 JPY +3.75% Intraday chart for Vital KSK Holdings, Inc. +3.83% +27.30%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Caution Ahead of US Inflation Data Leaves Japanese Shares Subdued MT
Vital KSK to Dispose of Treasury Shares Worth 108 Million Yen as Restricted Stock Compensation MT
Vital KSK Board OKs Up to 3 Billion Yen Share Buyback MT
Vital KSK Holdings, Inc. Announces Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 5, 2024; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2025 CI
Vital KSK Holdings, Inc. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2025 CI
Vital KSK Holdings, Inc. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2025 CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 2,000,000 shares, representing 3.85% for ¥3,000 million. CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan. CI
Vital KSK Holdings, Inc. Revises Consolidated Earnings Guidance for the Year Ended March 31, 2024 CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on November 6, 2023. CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on November 6, 2023, has closed with 600,000 shares, representing 1.18% for ¥669.6 million. CI
Vital KSK Holdings, Inc. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 5, 2023 CI
Vital KSK Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 700,000 shares, representing 1.38% for ¥840 million. CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan. CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 12, 2023. CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on May 12, 2023, has closed with 1,000,000 shares, representing 1.94% for ¥956.92 million. CI
VITAL KSK HOLDINGS, INC. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2024 CI
VITAL KSK HOLDINGS, INC. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024 CI
VITAL KSK HOLDINGS, INC. Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Vital KSK Holdings, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 12, 2023. CI
Vital KSK Announces Voting Results CI
Vital KSK Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 1,000,000 shares, for ¥1,200 million. CI
Chart Vital KSK Holdings, Inc.
More charts
VITAL KSK HOLDINGS, INC. is a Japan-based holding company, principally engaged in the wholesale of drugs. The Pharmaceutical Wholesale segment is engaged in the wholesale of pharmaceuticals, diagnostics, medical equipment, materials to hospitals, medical practitioners, pharmacies and other medical institutions. The others business is engaged in dispensing pharmacy business, retail of pharmaceutical products, wholesale of agricultural chemicals and veterinary drugs, transportation business, nursing care business, consulting services for medical institutions, property insurance agency business, real estate brokerage business, as well as parking business.
More about the company
  1. Stock Market
  2. Equities
  3. 3151 Stock
  4. News Vital KSK Holdings, Inc.
  5. Vital KSK Board OKs Up to 3 Billion Yen Share Buyback